Dr. T. Vandepaer - Reumatologie SRL

Dr. T. Vandepaer - Reumatologie reported total assets of 65,545 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Jan 2026).

Company number (CBE) 1014.576.646
2800 Mechelen
active in Medical specialists activities (NACE 86220)
operating since 03 Oct 2024 (≈ 2 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. T. Vandepaer - Reumatologie shows with a free account.

See the score
Profile
SRL since 2024
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result44,029 €
Equity44,030 €
Cash20,217 €
EBITDA55,817 €
Total assets65,545 €
The line marks its sector median: 72.2% (8672 companies).

Accounts of the company itself (not consolidated).

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. T. Vandepaer - Reumatologie's annual accounts

2025
Net result44,029 €
Equity44,030 €
Cash20,217 €
EBITDA55,817 €
Total assets65,545 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 13 Jan 2026

Dr. T. Vandepaer - Reumatologie's financial analysis

Management and control of Dr. T. Vandepaer - Reumatologie

1 active director(s) in the register.

Dr. T. Vandepaer - Reumatologie's shareholders and holdings →

Dr. T. Vandepaer - Reumatologie's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
1014.576.646
VAT number
No VAT activity declared to the CBE
Peppol
Registered · 0208:1014576646 · as of 10 Nov 2026
Legal form
SRL
Incorporated
03 Oct 2024
Registered office
2800 Mechelen
Latest accounts
2025 · filed on 13 Jan 2026
Activity
Medical specialists activities (NACE 86220)

Dr. T. Vandepaer - Reumatologie (SRL) has been based in Mechelen since 2024, active in: medical specialists activities. For 2025, it reports a net profit of 44,029 € and equity of 44,030 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. T. Vandepaer - Reumatologie

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. T. Vandepaer - Reumatologie

What is the revenue of Dr. T. Vandepaer - Reumatologie?

Dr. T. Vandepaer - Reumatologie files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. T. Vandepaer - Reumatologie?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. T. Vandepaer - Reumatologie. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE1014576646. Its company number (CBE) is 1014.576.646.

Where is the registered office of Dr. T. Vandepaer - Reumatologie?

According to the CBE register, the registered office of Dr. T. Vandepaer - Reumatologie is in 2800 Mechelen.

What is the equity of Dr. T. Vandepaer - Reumatologie?

At the close of the 2025 financial year, the equity of Dr. T. Vandepaer - Reumatologie amounts to 44,030 €, a solvency of 67.2% of total assets.

Who manages Dr. T. Vandepaer - Reumatologie?

The register lists 1 active mandates at Dr. T. Vandepaer - Reumatologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. T. Vandepaer - Reumatologie

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 12 Sep 2026

No credit card, no commitment.

What each plan unlocks →